Vivos Therapeutics, Inc. (Nasdaq: VVOS) announced the opening of a sleep testing and treatment facility in Henderson, Nevada, scheduled for a grand opening on Aug. 27, 2026, according to a company press release.

The company said the new location is expected to more than double its annual revenue production capacity in Henderson to over $10 million. At full capacity, the facility is projected to employ up to 30 personnel, including board-certified medical doctors, dentists, nurse practitioners, and clinical support staff, as part of the company's Sleep Centers of Nevada network.

R. D. Prabhu, M.D., founder and chief medical officer of Sleep Centers of Nevada, said the facility brings together two specialized teams to deliver sleep medicine care, including diagnostic testing, clinical evaluation, and treatments such as FDA-cleared oral appliance therapy, airway-focused dental sleep medicine, laser therapy, and myofunctional therapy.

Chief Executive Officer Kirk Huntsman said total incoming referrals across the Las Vegas market have more than doubled since May and June 2026, and that the new center represents the company's "most refined platform model."

Vivos, headquartered in Littleton, Colorado, develops diagnostic and treatment products for obstructive sleep apnea and other sleep disorders. Its devices have received FDA clearance for adult patients with all severity levels of obstructive sleep apnea, as well as for children ages 6 to 17 with moderate-to-severe obstructive sleep apnea.